North America severe asthma market is set for growth, driven by high asthma prevalence, increased awareness, and advanced treatment options for severe cases. Ankush Nikam Future Market Insights, Inc.
The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations have increased by an average 98% since they hit the market, according to a ...
BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the results of a new survey, revealing that 72% of women in the United States have delayed having a ...